Murakami K, Fujioka T, Shiota K, Ito A, Fujiyama K, Kodama R, Kawasaki Y, Kubota T, Nasu M
Second Department of Internal Medicine, Oita Medical University, Japan.
Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S93-7.
The aim of the present study was to clarify the effects of Helicobacter pylori infection and its eradication on gastric emptying.
Out of a total of 52 patients with non-ulcerative dyspepsia, 34 H.pylori-positive patients were enrolled. Antimicrobial drugs for the eradication of H. pylori were administered to 19 out of the 34 H. pylori-positive patients. Gastric emptying was evaluated according to the acetaminophen method. Inflammatory changes and intracellular periodic acid-Schiff-positive substances in the antral mucosa were examined in biopsy specimens.
Although gastric emptying was significantly prolonged in the patients with non-ulcerative dyspepsia compared with the control group (P < 0.01), there was no difference in gastric emptying between H. pylori-positive and -negative patients, with all patients showing significantly less gastric emptying than the control group. The H. pylori eradication rate was 58% (11 out of 19) and gastric emptying improved significantly in seven patients whose infection was eradicated and whose dyspeptic symptoms disappeared. The ammonia concentration in gastric juice, inflammatory changes in the gastric mucosa and the index of periodic acid-Schiff-positive substances improved significantly when H. pylori was successfully eradicated compared with patients in whom eradication was unsuccessful. As gut hormones may affect gastroduodenal motility associated with H. pylori infection, we also studied the levels of serum gastrin and cholecystokinin. In the patients whose infection was eradicated, serum gastrin decreased significantly, but the cholecystokinin level did not change significantly, although there was a non-significant trend for cholecystokinin to increase.
These results suggest that delayed gastric emptying is partly associated with H. pylori infection and that the infection may contribute to the development of non-ulcerative dyspepsia.
本研究旨在阐明幽门螺杆菌感染及其根除对胃排空的影响。
在总共52例非溃疡性消化不良患者中,纳入34例幽门螺杆菌阳性患者。34例幽门螺杆菌阳性患者中的19例接受了根除幽门螺杆菌的抗菌药物治疗。根据对乙酰氨基酚法评估胃排空情况。在活检标本中检查胃窦黏膜的炎症变化和细胞内过碘酸希夫阳性物质。
与对照组相比,非溃疡性消化不良患者的胃排空明显延长(P < 0.01),幽门螺杆菌阳性和阴性患者之间的胃排空没有差异,所有患者的胃排空均明显低于对照组。幽门螺杆菌根除率为58%(19例中的11例),7例感染被根除且消化不良症状消失的患者胃排空明显改善。与根除失败的患者相比,成功根除幽门螺杆菌后,胃液中的氨浓度、胃黏膜炎症变化和过碘酸希夫阳性物质指数均明显改善。由于肠道激素可能影响与幽门螺杆菌感染相关的胃十二指肠运动,我们还研究了血清胃泌素和胆囊收缩素的水平。在感染被根除的患者中,血清胃泌素明显下降,但胆囊收缩素水平没有明显变化,尽管胆囊收缩素有非显著性升高趋势。
这些结果表明,胃排空延迟部分与幽门螺杆菌感染有关,且该感染可能促成非溃疡性消化不良的发生。